| MARITIMA DEL CALLAO | 2025 | 1500 | KG | 2-BUTYL-4-CHLORO-1-[P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL]IMIDAZOLE-5-METHANOL, MONOPOTASSIUM 2-BUTYL-4-CHLORO-1-[P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL]IMIDAZOLE-5-METHANOL, MONOPOTASSIUM MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KGS | CHINA | CHINA | 68042 |
| MARITIMA DEL CALLAO | 2025 | 300 | KG | L-PROLINE,1-(N-(1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)-,(S),(Z)-2-BUTENEDIOATE(1:1), L-PROLINE,1-(N-(1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)-L-ALANYL)-,(S),(Z)-2-BUTENEDIOATE(1:1) MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN K | CHINA | CHINA | 39110.2 |
| MARITIMA DEL CALLAO | 2025 | 1800 | KG | 3-BUTYL-2-[[4-[2-(2H-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]-2,4-DIAZASPIRO(4,4)NON-3-EN-1-ONE 3-BUTYL-2-[[4-[2-(2H-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]-2,4-DIAZASPIRO(4,4)NON-3-EN-1-ONE MATERIA PRIMA PARA PREPARACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KIL | CHINA | CHINA | 90675.9 |
| MARITIMA DEL CALLAO | 2025 | 1500 | KG | 2-BUTYL-4-CHLORO-1-[P-(O-IH-TETRAZOL-5-YLPHENYL)BENZYI]IMIDAZOLE-5METHANOL, MONOPOTASSIUM 2-BUTYL-4-CHLORO-1-[P-(O-IH-TETRAZOL-5-YLPHENYL)BENZYI]IMIDAZOLE-5METHANOL, MONOPOTASSIUM LOSARTAN POTASICO Materia prima para fabricación de medicamentos | CHINA | CHINA | 70291.5 |
| MARITIMA DEL CALLAO | 2025 | 800 | KG | 3-BUTYL-2-[[4-[2-(2H-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]-2,4-DIAZASPIRO(4,4)NON-3-EN-1-ONE 3-BUTYL-2-[[4-[2-(2H-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]-2,4-DIAZASPIRO(4,4)NON-3-EN-1-ONE Materia Prima para preparación de medicamentos COMERCIALIZADO EN KGS | CHINA | CHINA | 40581.1 |
| AEREA Y POSTAL EX-IAAC | 2025 | 5.2 | KG | ACIDO ZOLEDRONICO IMPUREZA B, S/M, S/M ZOLEDRONIC ACID IMPURITY B CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO PRESENTACIÓN: 1 VIAL X 15 MG, Y0002027, LOTE: L02.00 | FRANCE | FRANCE | 180.44 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.098 | KG | NITRATO DE POTASIO (USP), USP, S/M POTASSIUM NITRATE (100 MG) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO COMERCIALIZADO EN UNIDADES R153G2 - IMO: UN1486 | UNITED STATES | UNITED STATES | 219.27 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.022 | KG | IRBESARTAN (USP), USP, S/M IRBESARTAN (200 MG) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO 1 VIAL X 200MG; 1347700;LOTE:R11500 | UNITED STATES | UNITED STATES | 269.13 |
| AEREA Y POSTAL EX-IAAC | 2025 | 1 | KG | 1-BENZYL-4-((5,6-DIMETHOXY-1-INDAMON)-2-YL)METHYLPIPERIDINE HYDROCHLORIDE, S/M, S/M 1-BENZYL-4-((5,6-DIMETHOXY-1-INDAMON)-2-YL)METHYLPIPERIDINE HYDROCHLORIDE MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 560 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.029 | KG | ETIONAMIDA PARA IDONEIDAD DE SISTEMA(EP), S/M, S/M Ethionamide for system suitability CRS PRESENTACION: 1 VIAL = 10 MG, CODIGO: 202400458, LOTE: L01.00 ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO ETIONAMIDA PARA IDONEIDAD DE SISTEMA(EP), S/M, S | FRANCE | FRANCE | 163.69 |
| AEREA Y POSTAL EX-IAAC | 2025 | 12 | KG | DEFERASIROX PARA ADECUACION DEL SISTEMA (EP), S/M, S/M Deferasirox for system suitability CRS ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO CODIGO: 202300263, PRESENTACION: 1 VIAL = 10 MG , LOTE: L02.00 | FRANCE | FRANCE | 174.2 |
| AEREA Y POSTAL EX-IAAC | 2025 | 0.015 | KG | DEFERASIROX IMPUREZA B (EP), S/M, S/M DEFERASIROX IMPUREZA B (EP) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO COMERCIALIZADO EN UNIDADES | FRANCE | FRANCE | 89.67 |